About
Introduction Faculty Partnerships Contacts
Research
Institutes & Laboratories Research News
Admissions
Graduate Academic Advisor Provisional Admission List
Technology Transfer
Tsientang Materials Laboratory Startup Companies
Campus
Hangzhou Campus Design Campus Life
Join Us
About Research Admissions Technology Transfer Campus Join Us
Introduction Faculty Partnerships Contacts
Institutes & Laboratories Research News
Graduate Academic Advisor Provisional  Admission List
Tsientang Materials Laboratory Startup Companies
Hangzhou Campus Design Campus Life
Join Us
0571-26692003
No. 181 Geyazhuang, Xihu District,Hangzhou, Zhejiang, P.R. China
Faculty

Related Links

Home / About / Faculty
Jingjing Zhao, Ph.D.
Jingjing Zhao, Ph.D.
Life Sciences

Dr. Jingjing Zhao received her Ph.D. from the School of Basic Medical Sciences, Peking University, in 2020. Her doctoral research primarily focused on tumor immunotherapy. In 2023, she completed her postdoctoral research at Tsinghua University, where she was involved in new drug applications and clinical development programs.

Her current research focuses on aging and age-related diseases, with an emphasis on elucidating the molecular mechanisms of cellular senescence and its role in disease pathogenesis. She aims to develop innovative therapeutic strategies for anti-aging and the treatment of various senescence-driven degenerative diseases.

  • Research Areas
    Dedicated to elucidating the molecular mechanisms of cellular senescence and its role in disease pathogenesis, with the goal of developing innovative therapeutic strategies for anti-aging and the treatment of various senescence-driven degenerative diseases.
  • Education
    2016-2020
    Ph.D. in Medical Cell Biology, School of Basic Medical Sciences, Peking University
    2012-2016
    B.Ec. in Economics (double Bachelor’s degree), National School of Development, Peking University
    2011-2016
    B. Med. in Basic Medicine Sciences, School of Basic Medical Sciences, Peking University
  • Work Experience
    2025-Present
    Assistant Professor, Laboratory of Aging and Regeneration, Tsientang Institute for Advanced Study
    2023-2025
    Senior Pharmacological Researcher, Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd.
    2021-2023
    Postdoctoral Fellow, School of Basic Medical Sciences, Tsinghua University
    2020-2021
    Pharmacological Researcher, Stem Cell Research Center, Peking University
  • Academic Achievements
    1. Zhao J, Dong J, Deng C, Zhang Q, Sun S, Li H, Bai Y, Deng H. Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor. Oncoimmunology. 2023;12(1):2265703.
    2. Lu S, Zhao J, Dong J, Liu H, Zhu Y, Li H, Liu L, Yang Y, Sun S, Song Y, et al. Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation. Cell Res. 2021;31(2):229-232.
    3. Deng C, Zhao J, Zhou S, Dong J, Cao J, Gao J, Bai Y, Deng H. The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors. Mol Ther. 2020;28(1):75-88.
    4. Teng R, Zhao J, Zhao Y, Gao J, Li H, Zhou S, Wang Y, Sun Q, Lin Z, Yang W, et al. Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model. J Immunother. 2019;42(2):33-42.
    5. Deng H, Luo T, Cai Y, Zhou H, Zhu Y, Zhao J, Dong J, Li H; Invention patent “SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF” (International publication number: WO 2021/057840).
Return